Information Provided By:
Fly News Breaks for November 7, 2016
AMED
Nov 7, 2016 | 09:00 EDT
As previously reported, Mizuho upgraded Amedisys to Buy from Neutral and maintained a $47 price target. Analyst Sheryl Skolnick said shares were weak on Friday due to another C-Suite change at the company, this time at the COO level. But she spoke with CEO Kusserow after the call and, combined with his answers to our questions during the call, she is more comfortable with the reasons for the change and with estimates.
News For AMED From the Last 2 Days
There are no results for your query AMED